Severe Misconduct, Repeat Offending And Underreporting: UK/EU Codes Come Under Fire

The UK and EU pharma industry associations have defended their respective codes of practice despite alarming study results. Meanwhile, a consultation on proposals to revise the UK code received over 3,500 comments.

A study has cast doubt on the effectiveness of self-regulatory codes of practice • Source: Shutterstock

The Association of the British Pharmaceutical Industry is standing by its code of practice after a study found that self-regulation in the UK was ineffective in preventing company misconduct, with the situation being even worse in most other parts of Europe.

Key Takeaways

A study of self-regulation in the UK and the ABPI’s code of practice has found evidence of persistent and often severe misconduct by companies in the UK.

"We believe that UK self-regulation works,” the ABPI’s Amit Aggarwal said of the study, which found evidence of “persistent and...